AP209 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

10 results for “AP209”

Trials

A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

168 participants · First posted Jul 25, 2022

Pilot Study of APD209 in Cancer Cachexia

13 participants · First posted May 8, 2009

The Efficacy of AP029 Mix in Patients With Impaired Carbohydrate Metabolism

30 participants · First posted Aug 16, 2023

Drugs

AP205-RBD

AP205-RBM

AP20 (Aprogen)

News

Aprogen Advances AP209, a Bispecific Receptor Osteoarthritis Drug, into Phase 1 Clinical Trials Following South Korean IND Approval